Anticancer activity of heterodinuclear ruthenium(II)–platinum(II) complexes as photochemotherapeutic agents

July 28, 2017

Title

Anticancer activity of heterodinuclear ruthenium(II)–platinum(II) complexes as photochemotherapeutic agents

Author

Takakazu Yano, Shota Hishida, Misaki Nakai, Yasuo Nakabayashi

Year

2016

Journal

Inorganica Chimica Acta

Abstract

The purpose of the present study was to investigate the DNA-binding properties of mononuclear ruthenium(II) complex [Ru(tBu2bpy)2(dpp)]2+ and heterodinuclear ruthenium(II)–platinum(II) complexes [Ru(tBu2bpy)2(μ-dpp)PtX2]2+ (X = Cl (1), Br (2), I (3)) and [Ru(bpy)2(μ-dpp)PtCl2]2+ (4). We presented the interaction study of the complexes with CT-DNA and the DNA photocleavage properties using pBR322 supercoiled plasmid DNA when irradiated with visible light and their cytotoxicity against HeLa cervical cancer cell line. All the complexes were cleavage inactive in the dark, while the photoinduced DNA cleavages were observed for these complexes. It appeared that the DNA photocleavage for [Ru(tBu2bpy)2(dpp)]2+ proceeded via a singlet oxygen pathway, whereas complexes 1–3 proceeded via a photoredox pathway. [Ru(tBu2bpy)2(dpp)]2+, 2, and 3 in the light displayed favorable cytotoxicity, which were in all cases similar to cisplatin. 2 (IC50 = 9.1 μM) which was less toxic than [Ru(tBu2bpy)2(dpp)]2+ (IC50 = 5.6 μM) produced the largest PI (>22), indicating a highly effective photocytotoxic agent. The order of cytotoxicity of 1–4 in the light may be due to the lipophilicity (2 > 3 > 1 ≫ 4).

Instrument

J-820

Keywords

Circular dichroism, DNA structure, Ligand binding, Inorganic chemistry, Coordination chemistry, Biochemistry